Research Advancements

Recent Research Shows Promise for New Parkinson’s-Symptoms Drugs

Researchers at Oregon Health & Science University have made a big discovery regarding Parkinson's.

Lecanemab Has FDA Approval, But Alzheimer’s Patients Should Proceed With Caution

Neurology Associates Neuroscience Center looks at the side effects of lecanemab, the newly FDA-approved drug for Alzheimer's.

Alzheimer’s Drug Lecanemab Could Get FDA Accelerated Approval This Week

A Neurology Associates Neuroscience Center blog about the pending FDA accelerated approval of experimental Alzheimer's drug lecanemab.

November: Spotlight on Alzheimer's, Epilepsy

Did you know? One in 10 people age 65 or older in the U.S. has Alzheimer’s disease. One in 26 people will develop epilepsy in their...

New Discoveries for Alzheimer’s, Parkinson’s, Epilepsy: A Roundup of Some of the Latest Research

The field of neurological research features so many developments it’s difficult to keep track of them all. Here’s a roundup of some of...

FDA Expedites Review Process of Medical Device That May Help Diagnose Parkinson’s Earlier

As researchers uncover evidence that measuring eye tremors may help diagnose Parkinson’s disease earlier, the U.S. Food and Drug...

Rockefeller Neuroscience Institute Researchers Looking for Alzheimer’s Candidates

They continue to conduct ground-breaking studies using focused ultrasound and magnetic stimulation Researchers at West Virginia...